VT News

Keiron Assiratti

Ask VT AI
View News Summary
  • Warner Bros. Discovery posts strong Q2 results, driven by studio successes and streaming growth, as it prepares to split into two entities.
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Krispy Kreme reports massive Q2 loss, triggering a turnaround plan focused on cost reduction and refranchising.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Warner Bros. Discovery posts strong Q2 results, driven by studio successes and streaming growth, as it prepares to split into two entities.
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Krispy Kreme reports massive Q2 loss, triggering a turnaround plan focused on cost reduction and refranchising.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Keiron Assiratti

Top Topics

Trending in U.S.

World

Sport